mAbs - International Biopharmaceutical Industry

Current Edition

Volume 4 Issue 4

SLIM: A Gateway to the Adoption of High-Resolution Ion Mobility for Biotherapeutic Peptide Mapping

The demand for protein therapeutics, such as recombinant human proteins, monoclonal antibodies (mAbs), and fusion proteins, has grown significantly over the past deca...

9 December 2021 Volume 4 Issue 4 Biotherapeutic | fusion proteins

Continue Reading →

Volume 4 Issue 4

Maximising mAbs Purification Efficiency: Focus Areas for Reducing Bottlenecks in Downstream Processing

Finding ways to remove bottlenecks and improve yields in downstream processing for monoclonal antibodies (mAbs) continues to be a key focus area for biopharma manufac...

9 December 2021 Volume 4 Issue 4 Bottlenecks | Downstream Processing

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

SLIM: A Gateway to the Adoption of High-Resolution Ion Mobility for Biotherapeutic Peptide Mapping

Maximising mAbs Purification Efficiency: Focus Areas for Reducing Bottlenecks in Downstream Processing

International Biopharmaceutical Industry